A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
MSI MAG B760 Tomahawk Wi-Fi Review
Influencer responds to criticism for demanding commuters wait for her when filming on tube
MrBeast’s girlfriend Thea Booysen recreates iconic ‘Disaster Girl’ meme, leaves fans in splits
How to delete your Amazon account
Cut your tech costs and save 69% on this refurbished iPad Air
FIFA 23 FUTTIES 'Best of' Batch 1 Player Pick: How to Complete
China deletes 1.4 million social media posts in crack down on 'self-media' accounts
What Happens to My Warzone 2 Items After MW3 Comes Out?
